Celldex Therapeutics
CLDX
#4701
Rank
โ‚ฌ1.68 B
Marketcap
25,29ย โ‚ฌ
Share price
-0.51%
Change (1 day)
-0.17%
Change (1 year)

Earnings for Celldex Therapeutics (CLDX)

Earnings in 2025 (TTM): -โ‚ฌ0.23 Billion

According to Celldex Therapeutics's latest financial reports the company's current earnings are โ‚ฌ2.6 Million. In 2024 the company made an earning of -โ‚ฌ0.17 Billion a decrease over its 2023 earnings that were of -โ‚ฌ0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Celldex Therapeutics from 1986 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ0.23 Billion36.51%
2024 -โ‚ฌ0.17 Billion37.34%
2023 -โ‚ฌ0.13 Billion32.63%
2022 -โ‚ฌ91.99 Million54.88%
2021 -โ‚ฌ59.4 Million39.49%
2020 -โ‚ฌ42.58 Million-9.08%
2019 -โ‚ฌ46.84 Million-28.64%
2018 -โ‚ฌ65.63 Million-30.11%
2017 -โ‚ฌ93.91 Million-17.75%
2016 -โ‚ฌ0.12 Billion4.5%
2015 -โ‚ฌ0.11 Billion4.09%
2014 -โ‚ฌ0.11 Billion51.57%
2013 -โ‚ฌ69.25 Million40.1%
2012 -โ‚ฌ49.43 Million
2010 -โ‚ฌ1.08 Million-96.59%
2009 -โ‚ฌ31.44 Million
2006 -โ‚ฌ19.22 Million
2004 -โ‚ฌ11.67 Million15.75%
2003 -โ‚ฌ10.08 Million-18.69%
2002 -โ‚ฌ12.4 Million-41.22%
2001 -โ‚ฌ21.09 Million59%
2000 -โ‚ฌ13.27 Million27.65%
1999 -โ‚ฌ10.39 Million53.12%
1998 -โ‚ฌ6.79 Million2.6%
1997 -โ‚ฌ6.62 Million-33.62%
1996 -โ‚ฌ9.97 Million-1.69%
1995 -โ‚ฌ10.14 Million22.92%
1994 -โ‚ฌ8.25 Million-0%
1993 -โ‚ฌ8.25 Million
1991 -โ‚ฌ5.07 Million90.32%
1990 -โ‚ฌ2.67 Million10.71%
1989 -โ‚ฌ2.41 Million833.33%
1988 -โ‚ฌ0.26 Million-400%
1987 โ‚ฌ0.08 M-125%
1986 -โ‚ฌ0.35 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Seagen
SGEN
-โ‚ฌ0.68 Billion 208.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚ฌ17.74 M-108.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.14 B-164.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ7.08 B-3,317.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ10.17 B-4,725.35%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ8.00 B-3,738.35%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
-โ‚ฌ2.41 Million-98.91%๐Ÿ‡บ๐Ÿ‡ธ USA